ArticleClinical journal of the American Society of Nephrology : CJASN2013
Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach.
Article in Clinical journal of the American Society of Nephrology : CJASN, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 76 citations in OpenAlex.
- Dynamic Medication Challenges in Hemodialysis: Rethinking Medication Therapy Management Strategies Through Longitudinal Trends.Kidney medicine · 2026Article
- Assessment of Drug Dosing Appropriateness in Hospitalized Chronic Kidney Disease Patients with Cardiovascular Diseases: A Cross-Sectional Study in the Al-Baha Region, Saudi Arabia (2023-2025).Journal of clinical medicine · 2026Article
- Effect of a Population Health Management Intervention on Medication Therapy Problems in People With Chronic Kidney Disease: Post Hoc Analysis of the K-CHAMP Cluster-Randomized Trial.Kidney medicine · 2025Article
- Factors associated with patient activation among patients with diabetes on hemodialysis: a multicenter cross-sectional study from a developing country.BMC nephrology · 2024Article
- Effect of medication therapy management services on medication-burden quality of life in hemodialysis patients.BMC nephrology · 2023Article
- Medication Review with Follow-Up for End-Stage Renal Disease: Drug-Related Problems and Negative Outcomes Associated with Medication-A Systematic Review.Journal of clinical medicine · 2023Review
- Determinants of medication adherence in hemodialysis patients: a cross-sectional study based on capability-opportunity-motivation and behavior model.BMC nephrology · 2023Article
- Choosing the right chronic medication for hemodialysis patients. A short ABC for the dialysis nephrologist.Journal of nephrology · 2023Review
- Balancing Risk and Uncertain Benefit in Pharmacotherapy for Pain in Kidney Transplant Recipients.Clinical journal of the American Society of Nephrology : CJASN · 2023Article
- Opioids for chronic pain management in patients with dialysis-dependent kidney failure.Nature reviews. Nephrology · 2022Review
- Assessment of Dietary Folate Intake and Pill Burden among Saudi Patients on Maintenance Hemodialysis.International journal of environmental research and public health · 2021Article
- Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017.American journal of nephrology · 2021Article
- Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2020Review
- Chronic drug treatment among hemodialysis patients: a qualitative study of patients, nursing and medical staff attitudes and approaches.BMC nephrology · 2020Article
- Dietitians can improve accuracy of prescribing by interacting with electronic prescribing systems.BMJ health & care informatics · 2019Article
- Polypharmacy in elderly cancer patients: Challenges and the way clinical pharmacists can contribute in resource-limited settings.Aging medicine (Milton (N.S.W)) · 2019Review
- Association between NSAID use and mortality risk in patients with end-stage renal disease: a population-based cohort study.Clinical epidemiology · 2019Article
- Medication Safety Principles and Practice in CKD.Clinical journal of the American Society of Nephrology : CJASN · 2018Review
- Assessing the effect of oral activated vitamin D on overall survival in hemodialysis patients: a landmark analysis.BMC nephrology · 2018Article
- Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing.Pharmacy (Basel, Switzerland) · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 6 institutions in 1 country.
Funding
Abstract
Patients with ESRD undergoing dialysis have highly complex medication regimens and disproportionately higher total cost of care compared with the general Medicare population. As shown by several studies, dialysis-dependent patients are at especially high risk for medication-related problems. Providing medication reconciliation and therapy management services is critically important to avoid costs associated with medication-related problems, such as adverse drug events and hospitalizations in the ESRD population. The Medicare Modernization Act of 2003 included an unfunded mandate stipulating that medication therapy management be offered to high-risk patients enrolled in Medicare Part D. Medication management services are distinct from the dispensing of medications and involve a complete medication review for all disease states. The dialysis facility is a logical coordination center for medication management services, like medication therapy management, and it is likely the first health care facility that a patient will present to after a care transition. A dedicated and adequately trained clinician, such as a pharmacist, is needed to provide consistent, high-quality medication management services. Medication reconciliation and medication management services that could consistently and systematically identify and resolve medication-related problems would be likely to improve ESRD patient outcomes and reduce total cost of care. Herein, this work provides a review of available evidence and recommendations for optimal delivery of medication management services to ESRD patients in a dialysis facility-centered model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.